Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed ...
Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...
Acceptance of respiratory syncytial virus (RSV) immunizations in the United States is growing, particularly for older adults, ...
Shanghai Henlius Biotech, Inc. Class H ( (HK:2696)) has shared an announcement. Shanghai Henlius Biotech has received approval from the U.S. Food and Drug Administration for its investigational new ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary Robert F. Kennedy Jr. No safety ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary Robert F. Kennedy Jr. No safety ...
Primary immune thrombocytopenia (ITP) is an autoimmune condition where the body’s immune cells mistakenly attack platelets, the blood cells responsible for clotting, which can lead to life-threatening ...
The FDA has released a plan to stop or reduce the use of primates for testing the safety of certain monoclonal antibodies (mAbs), the latest expansion of the regulator’s efforts to eliminate animal ...
New guidelines recommend doctors tackle Crohn's disease head-on, calling for the use of cutting-edge drugs as early as possible to quell the autoimmune GI disorder as quickly as possible. The updated ...
THURSDAY, Nov. 20, 2025 (HealthDay News) — New guidelines recommend doctors tackle Crohn’s disease head-on, calling for the use of cutting-edge drugs as early as possible to quell the autoimmune GI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results